Edition:
United States

Prima BioMed Ltd (PBMD.OQ)

PBMD.OQ on NASDAQ Stock Exchange Global Market

1.55USD
22 Aug 2017
Change (% chg)

-- (--)
Prev Close
$1.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,980
52-wk High
$3.25
52-wk Low
$1.40

PBMD.OQ

Chart for PBMD.OQ

About

Prima BioMed Ltd is a biotechnology company. The Company is engaged in research, development and commercialization of licensed medical biotechnology. It is also focused on development of immunotherapeutic products. The Company operates through Cancer Immunotherapy segment. Its core technologies are based on the Lymphocyte-activa... (more)

Overall

No Ratios Available.

Financials

  PBMD.OQ Industry Sector
P/E (TTM): -- 78.70 32.82
EPS (TTM): -- -- --
ROI: -- 3.22 14.97
ROE: -- 5.08 16.21

BRIEF-Prima BioMed announces second milestone payment for IMP701 program

* it will receive a second undisclosed significant clinical milestone payment from Novartis

Jul 16 2017

BRIEF-Prima Biomed ‍received approval for intiation of ‘Insight’ clinical trial

* Received regulatory and ethical approvals for clinical trial investigating IMP321 in new settings, called Insight​

Jul 09 2017

BRIEF-Prima Biomed enters securities purchase agreement to purchase 2.6 mln of its American Depositary shares

* Entered into a securities purchase agreement with certain accredited investors to purchase 2.6 million of its american depositary shares

Jun 29 2017

BRIEF-Prima Biomed announces pricing of direct offering of its American Depositary Shares

* Prima Biomed Ltd announces pricing of $5.0 million registered direct offering of its American depositary shares

Jun 29 2017

Earnings vs. Estimates